Share Your Feedback
Dyno Therapeutics
We build AI-powered gene therapies.
Funding
Growth Stage
Current Stage
$100M
Recent Funding
$109M
Total Funding
Leadership Team
Sam Sinai
VP, Head of Machine Learning
Adrian Veres
Chief Scientific Officer (CSO)Recent News
Dyno Therapeutics license exercised by Astellas for muscle delivery
Longevity.Technology
Can AI Agents Automate Scientific Discovery?
Genetic Engineering News
